(IXJ) Global Healthcare - Overview
ETF Category: Health | Exchange: NYSE ARCA (USA) | Market Cap: 3.668m USD | Total Return: 12% in 12m
Avg Turnover: 10.2M
Warnings
Extended 3d Choppy
Tailwinds
No distinct edge detected
The iShares Global Healthcare ETF (IXJ) seeks to track the investment results of an index composed of global equities within the healthcare sector. The fund maintains a policy of investing at least 80% of its assets in the component securities of its underlying index, which includes pharmaceutical, biotechnology, and medical device companies.
The healthcare sector is characterized by high research and development (R&D) costs and long regulatory approval cycles, often resulting in significant intellectual property moats for established firms. Many businesses in this space utilize a recurring revenue model driven by chronic disease management and essential medical procedures.
Investors can further evaluate the underlying valuations of these healthcare holdings at ValueRay. This ETF provides exposure to large-cap companies deemed essential to global markets by S&P Dow Jones Indices.
- FDA drug approval timelines and clinical trial outcomes dictate pharmaceutical revenue growth
- Global aging demographics increase long-term demand for healthcare services and medical devices
- US drug price negotiation mandates under the Inflation Reduction Act impact margins
- Strengthening US dollar reduces international revenue conversion for multinational healthcare constituents
- Research and development spending levels influence innovation cycles in biotechnology and diagnostics
As of June 08, 2026, the stock is trading at USD 95.63 with a total of 181,023 shares traded.
Over the past week, the price has changed by +1.20%,
over one month by +3.95%,
over three months by -1.79% and
over the past year by +11.95%.
Global Healthcare has no consensus analysts rating.